Previsioni di mercato per il trattamento dell\'ematuria in Sud e Centro America fino al 2028 - Impatto del COVID-19 e analisi regionale per trattamento (farmaci, terapie e altri), indicazione (infezioni del tratto urinario, calcoli renali, uretrite, cancro del sangue, calcoli alla vescica, cancro alla prostata, cistite) , traumi, esercizio fisico intenso, malattia renale policistica, endometriosi e mestruazioni), tipo (ematuria macroscopica, ematuria microscopica, ematuria idiopatica ed ematuria da jogging), utente finale (ospedali, cliniche e centri chirurgici ambulatoriali e altri)
Introduzione al mercato
L\'ematuria è una condizione medica in cui si riscontra la presenza di sangue nelle urine . Generalmente, l\'urina non contiene globuli rossi e quindi ciò può causare problemi seri che possono anche causare calcoli renali, infezioni del tratto urinario e altre malattie ereditarie.
Inoltre, l\'ematuria ad alta prevalenza Si prevede che le indicazioni associate rafforzeranno la crescita del mercato durante il periodo di previsione. Tuttavia, i casi non diagnosticati di indicazioni associate limitano la crescita del Sud & Mercato del trattamento dell\'ematuria in America Centrale.
La pandemia di SARS-CoV-2 ha avuto un impatto improvviso e drammatico sull\'assistenza sanitaria della regione SCAM. La pandemia di COVID-19 ha modificato il trattamento accettato e di routine dei casi elettivi nell’amministrazione ospedaliera. Il Sud e il Centro America non fanno eccezione. Ora si applicano rigorose procedure di distanziamento sociale, con i pazienti ricoverati in clinica non accompagnati e individualmente. Il CoViD-19 ha cambiato la vita quotidiana in quasi tutto il mondo. Nel complesso, l’entità di questa interruzione è dovuta ai timori individuali e alle azioni a livello di governo rispetto all’impatto locale della pandemia. Tuttavia, potrebbero esserci momenti in cui le misure restrittive vengono messe in atto nelle fasi iniziali, quando non si conosce la rapida evoluzione del problema, per garantire la salute della comunità. In Argentina, questa è stata la situazione che ha paralizzato l’assistenza medica programmata. Tali restrizioni potrebbero avere un impatto negativo sulle attività di ricerca e sviluppo, frenando direttamente la crescita del mercato del trattamento dell\'ematuria nella regione.
Panoramica e dinamiche del mercato
Il Sud & Si prevede che il mercato del trattamento dell’ematuria in America Centrale raggiungerà i 65,7 milioni di dollari entro il 2028 rispetto ai 57,8 milioni di dollari del 2021; si prevede che crescerà a un CAGR dell\'1,8% dal 2021 al 2028. Gli sviluppi tecnologici nei dispositivi medici e nelle procedure diagnostiche hanno portato a varie opzioni per la gestione delle indicazioni associate all\'ematuria, come calcoli renali, calcoli alla vescica e infezioni del tratto urinario. Si prevede che l’uso di tecnologie di trattamento avanzate migliorerà la cura dei pazienti. Ad esempio, negli ultimi anni ha guadagnato popolarità l’implementazione della robotica negli interventi chirurgici per il trattamento dell’urolitiasi. Attualmente, Vinci Surgical System, di Intuitive Surgical Inc., è ampiamente utilizzato nell\'esecuzione di interventi chirurgici per il trattamento dell\'urolitiasi. Allo stesso modo, la diffusione degli interventi endourologici per i calcoli renali è aumentata in modo significativo in vari paesi. Si prevede inoltre che i progressi nelle indicazioni associate possano sostenere il Sud e il Sud America. Mercato del trattamento dell\'ematuria in America Centrale durante il periodo di previsione.
Segmenti chiave del mercato
< p>In termini di tipologia, il segmento dell\'ematuria macroscopica rappresentava la quota maggiore del Sud & Mercato del trattamento dell\'ematuria in America Centrale nel 2020. In termini di trattamento, il segmento dei farmaci rappresentava la quota maggiore del Sud & Mercato del trattamento dell\'ematuria in America Centrale nel 2020. In termini di indicazione, il segmento delle infezioni del tratto urinario rappresentava la quota maggiore del Sud & Mercato del trattamento dell\'ematuria in America Centrale nel 2020. In termini di utente finale, il segmento degli ospedali rappresentava la quota maggiore del Sud & Mercato del trattamento dell\'ematuria in America Centrale nel 2020.Principali fonti e società elencate
< p>Alcune delle principali fonti primarie e secondarie a cui si fa riferimento per la preparazione di questo rapporto sul mercato del trattamento dell\'ematuria nel Sud & In America Centrale si trovano siti web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e database statistici, tra gli altri. Le principali aziende elencate nel rapporto sono AstraZeneca, Bristol-Myers Squibb Company, F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline plc., Janssen Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd e Boehringer Ingelheim International GmbH.Rapporto sui motivi per acquistare
- Per comprendere il Sud e l\'Europa Panorama del mercato del trattamento dell\'ematuria in America Centrale e identificare i segmenti di mercato che potrebbero garantire un forte rendimento
- Comprendere il panorama del mercato in continua evoluzione e rimanere al passo con la concorrenza
- Per pianificare in modo efficiente fusioni, acquisizioni e accordi di partnership nel Sud & Mercato del trattamento dell\'ematuria in America Centrale identificando i segmenti con le vendite probabili più promettenti
- Prendere decisioni aziendali consapevoli partendo da un\'analisi percettiva e completa delle prestazioni di mercato dei vari segmenti
- Per ottenere previsioni sui ricavi del mercato del Sud & Mercato del trattamento dell\'ematuria in America Centrale basato su vari segmenti per il periodo dal 2021 al 2028
SUD e Stati Uniti. SEGMENTAZIONE DEL MERCATO DEL TRATTAMENTO DELL’EMATURIA IN AMERICA CENTRALE
Per < span>Trattamento
- Farmaci
- Terapie
- Altri
Per indicazione
- Infezioni del tratto urinario
- Calcoli renali
- Uretrite
- Cancro al sangue
- Calcoli alla vescica
- Cancro alla prostata
- Cistite
- Trauma
- Esercizio fisico intenso
- < span>Malattia renale policistica
- Endometriosi
- Mestruazioni
Per tipo
- Ematuria macroscopica
- Ematuria microscopica
- Ematuria idiopatica
- Ematuria del pareggiatore
Per utente finale
- Ospedali span>
- Cliniche
- Centri chirurgici ambulatoriali (ASC)
- Altri
Per paese
- Sud e; America Centrale
- Brasile
- Argentina
- Resto del Sud e Stati Uniti. America Centrale
Società menzionate
- AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- < span>Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Hematuria Treatment Market – By Treatment
1.3.2 South & Central America Hematuria Treatment Market – By Indication
1.3.3 South & Central America Hematuria Treatment Market – By Type
1.3.4 South & Central America Hematuria Treatment Market – By End User
1.3.5 South & Central America Hematuria Treatment Market – By Country
2. South & Central America Hematuria Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Hematuria Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America – PEST Analysis
4.3 Experts Opinion
5. Hematuria Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Hematuria-Associated Indications
5.1.2 Increasing Awareness About Treatment Options and Improving Healthcare Expenditure
5.2 Market Restraints
5.2.1 Undiagnosed Cases of Associated Indications
5.3 Market Opportunities
5.3.1 Increasing Opportunities for Related Treatments
5.4 Future Trends
5.4.1 Rise in Preference for Advanced Therapies
5.5 Impact Analysis
6. Hematuria Treatment Market – South & Central America Analysis
6.1 South & Central America Hematuria Treatment Market Revenue Forecast and Analysis
7. Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment
7.1 Overview
7.2 South & Central America Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
7.3 Drugs
7.3.1 Overview
7.3.2 Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Therapies
7.4.1 Overview
7.4.2 Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Others
7.5.1 Overview
7.5.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8. Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication
8.1 Overview
8.2 South & Central America Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
8.3 Kidney Stones
8.3.1 Overview
8.3.2 Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Urinary Tract Infections (UTI)
8.4.1 Overview
8.4.2 Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Urethritis
8.5.1 Overview
8.5.2 Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Blood Cancer
8.6.1 Overview
8.6.2 Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Bladder Stones
8.7.1 Overview
8.7.2 Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Prostate Cancer
8.8.1 Overview
8.8.2 Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.9 Cystitis
8.9.1 Overview
8.9.2 Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.10 Trauma
8.10.1 Overview
8.10.2 Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.11 Vigorous Exercise
8.11.1 Overview
8.11.2 Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.12 Polycystic Kidney Disease
8.12.1 Overview
8.12.2 Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.13 Endometriosis
8.13.1 Overview
8.13.2 Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.14 Menstruation
8.14.1 Overview
8.14.2 Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
9. Hematuria Treatment Market Revenue and Forecast To 2028 – By Type
9.1 Overview
9.2 South & Central America Hematuria Treatment Market, By Type 2020 & 2028 (%)
9.3 Macroscopic Hematuria
9.3.1 Overview
9.3.2 Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.4 Microscopic Hematuria
9.4.1 Overview
9.4.2 Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.5 Idiopathic Hematuria
9.5.1 Overview
9.5.2 Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.6 Jogger’s Hematuria
9.6.1 Overview
9.6.2 Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
10. Hematuria Treatment Market Revenue and Forecast To 2028 – By End User
10.1 Overview
10.2 South & Central America Hematuria Treatment Market Share by End User 2020 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Clinics
10.4.1 Overview
10.4.2 Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Ambulatory Surgical Centers (ASC’s)
10.5.1 Overview
10.5.2 Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Others
10.6.1 Overview
10.6.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
11. South & Central America Hematuria Treatment Market – Geographic Analysis
11.1 South and Central America: Hematuria Treatment Market
11.1.1 Overview
11.1.2 South and Central America: Hematuria Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.3 South and Central America Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.4 South and Central America: Hematuria Treatment Market, by Indication – 2020–2028 (USD Million)
11.1.5 South and Central America Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
11.1.6 South and Central America Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
11.1.7 South and Central America: Hematuria Treatment Market Share by Country – 2021 & 2028, (%)
11.1.7.1 Brazil: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.1.7.1.1 Brazil: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.1.7.1.2 Brazil Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.3 Brazil: Hematuria Treatment Market, by Indication – 2020–2028 (USD Million)
11.1.7.1.4 Brazil Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.5 Brazil Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.2 Argentina: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.1.7.2.1 Argentina: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.1.7.2.2 Argentina Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.3 Argentina: Hematuria Treatment Market, by Indication – 2020–2028 (USD Million)
11.1.7.2.4 Argentina Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.5 Argentina Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.3 Rest of South and Central America: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.1.7.3.1 Rest of South and Central America: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.1.7.3.2 Rest of South and Central America Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.3 Rest of South and Central America: Hematuria Treatment Market, by Indication – 2020–2028 (USD Million)
11.1.7.3.4 Rest of South and Central America Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.5 Rest of South and Central America Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Hematuria Treatment Market
12.1 South & Central America: Impact Assessment of COVID-19 Pandemic
13. Hematuria Treatment Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 AstraZeneca
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bristol-Myers Squibb Company
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 F. HOFFMANN-LA ROCHE LTD.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline Plc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Janssen Pharmaceuticals
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck & Co., Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Novartis AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Sun Pharmaceutical Industries Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Boehringer Ingelheim International GmbH
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. South and Central America Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
Table 2. South and Central America Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 3. South and Central America Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million
Table 4. South and Central America Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Thousand)
Table 5. Brazil Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
Table 6. Brazil Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 7. Brazil Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Brazil Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Argentina Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
Table 10. Argentina Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 11. Argentina Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Argentina Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of South and Central America Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of South and Central America Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of South and Central America Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of South and Central America Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Organic Developments Done by Companies
Table 18. Inorganic Developments Done by Companies
Table 19. Glossary of Terms, Hematuria Treatment Market
LIST OF FIGURES
Figure 1. Hematuria Treatment Market Segmentation
Figure 2. South & Central America Hematuria Treatment Market Overview
Figure 3. Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market
Figure 4. Brazil to Show Significant Growth During Forecast Period
Figure 5. South & Central America Hematuria Treatment Market, Industry Landscape
Figure 6. South & Central America PEST Analysis
Figure 7. Hematuria Treatment Market Impact Analysis of Drivers and Restraints
Figure 8. South & Central America Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. South & Central America Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
Figure 10. Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 11. Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 12. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 13. South & Central America Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
Figure 14. Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 15. Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 16. Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 17. Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 18. Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 19. Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 20. Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 21. Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 22. Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 23. Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 24. Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 25. Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 26. South & Central America Hematuria Treatment Market, by Type 2020 & 2028 (%)
Figure 27. Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 28. Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 29. Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 30. Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 31. South & Central America Hematuria Treatment Market Share by End User 2020 & 2028 (%)
Figure 32. Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 33. Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 34. Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 35. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 36. South and Central America: Hematuria Treatment Market, By Key Country – Revenue (2021) (USD Million)
Figure 37. South and Central America: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
Figure 38. South and Central America: Hematuria Treatment Market Share by Country – 2021 & 2028, (%)
Figure 39. Brazil: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
Figure 40. Argentina: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
Figure 41. Rest of South and Central America: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
Figure 42. Impact Of COVID-19 Pandemic in South & Central America Country Markets
Figure 43. Growth Strategies Done by the Companies in the Market, (%)
- AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America hematuria treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.